Salesforce.com (CRM) Q2 2022 Earnings Call Transcript

CRM earnings call for the period ending June 30, 2021. Read More...

Motley Fool

Why Shares of Moderna and Novavax Are Higher This Morning

Shares of Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) are 2.7% and 3.5% higher, respectively, as of 11:10 a.m. EDT today, after more news showing booster shots are likely in the cards for those who have received a COVID-19 vaccine. With many of those in the U.S. and U.K. already receiving their jab, and the delta variant circulating, much of Wall Street’s work has been trying to calculate how much of an opportunity booster shots represents. In the U.K., the two will participate in a government-funded study named Octave Duo — along with Pfizer (NYSE: PFE) — to evaluate the effectiveness of an additional shot for people with weaker immune systems.

Read More